Ken Hallenbeck earned a Ph.D. in pharmaceutical sciences from the University of California, San Francisco, and now is an early drug discovery researcher. He loves to think and write about the future of scientific research. He serves on the board of directors of ReImagine Science, a nonprofit who empowers and connects scientist advocates, and is the Life Sciences Lead at TerraPrime, working with startups who aim to disrupt the scientific publication and education systems.